AXGN Q1 2022 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M-0.1% YoY

Gross Profit

$25M82.1% margin

Operating Income

-$11M-36.5% margin

Net Income

-$11M-37.0% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

-1.7%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$198M

Total Liabilities

$94M

Stockholders' Equity

$104M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$31M	-0.1%
Gross Profit	$25M	$26M	-1.6%
Operating Income	-$11M	-$6M	-82.0%
Net Income	-$11M	-$7M	-72.3%